Phoenix Biotech Acquisition Corp.
NASDAQ:PBAX
5.85 (USD) • At close February 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | |
|---|---|---|
| Assets: | ||
| Current Assets: | ||
| Cash & Cash Equivalents
| 0.476 | 1.099 |
| Short Term Investments
| 0 | 0 |
| Cash and Short Term Investments
| 0.476 | 1.099 |
| Net Receivables
| 0 | 0 |
| Inventory
| 0 | 0 |
| Other Current Assets
| 0.225 | 0.263 |
| Total Current Assets
| 42.367 | 1.361 |
| Non-Current Assets: | ||
| Property, Plant & Equipment, Net
| 0 | 0 |
| Goodwill
| 0 | 0 |
| Intangible Assets
| 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 |
| Long Term Investments
| 0 | 178.5 |
| Tax Assets
| 0 | 0.07 |
| Other Non-Current Assets
| 0 | 0.148 |
| Total Non-Current Assets
| 0 | 178.717 |
| Total Assets
| 42.367 | 180.078 |
| Liabilities & Equity: | ||
| Current Liabilities: | ||
| Account Payables
| 1.653 | 0.014 |
| Short Term Debt
| 0.65 | 0 |
| Tax Payables
| 0.599 | 0.08 |
| Deferred Revenue
| 0 | 0 |
| Other Current Liabilities
| 27.846 | 0.003 |
| Total Current Liabilities
| 30.748 | 0.098 |
| Non-Current Liabilities: | ||
| Long Term Debt
| 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 |
| Other Non-Current Liabilities
| 9.15 | 0 |
| Total Non-Current Liabilities
| 9.15 | 9.15 |
| Total Liabilities
| 39.898 | 9.248 |
| Equity: | ||
| Preferred Stock
| 0 | 0 |
| Common Stock
| 13.225 | 178.501 |
| Retained Earnings
| -10.756 | -7.67 |
| Accumulated Other Comprehensive Income/Loss
| 13.225 | 178.501 |
| Other Total Stockholders Equity
| 0 | 0 |
| Total Shareholders Equity
| 2.469 | 170.83 |
| Total Equity
| 2.469 | 170.83 |
| Total Liabilities & Shareholders Equity
| 42.367 | 180.078 |